AbbVie is the 11th pharmaceutical maker to impose limits on 340B contract pharmacy.
Breaking News
Breaking News: AbbVie Becomes 11th Drug Maker to Restrict 340B Contract Pharmacy. Feds Appeal Rulings in Lilly, Novo Nordisk, and Sanofi Cases.
AbbVie today announced conditions on 340B pricing when hospitals’ contract pharmacies dispense medicines to patients. The federal government has filed notices of appeal in Lilly, Novartis, Novo Nordisk, Sanofi, and United Therapeutics’ 340B contract pharmacy lawsuits.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.